XML 25 R14.htm IDEA: XBRL DOCUMENT v3.22.1
Note 8 - Warrants
3 Months Ended
Mar. 31, 2022
Notes to Financial Statements  
Class of Warrant or Right [Text Block]

8.

WARRANTS  

 

The changes in warrants are as follows:

 

  

Number of

warrants

  

Weighted

average

exercise price

 

Warrants outstanding, December 31, 2020

  12,500,000  $0.001 

Granted

  4,900,000   1.00 

Warrants outstanding, December 31, 2021 and March 31, 2022

  17,400,000  $0.28 

 

Details of warrants outstanding as at December 31, 2021 are as follows:

 

Exercise price

 

Number of

warrants

outstanding

 

Expiry date

 

Number of

warrants

exercisable

  

Remaining

contractual life

(years)

 
                
$1.00

 (CAD)

  4,900,000 

April 19, 2023

  4,900,000   1.05 
$0.001

(1)  (USA)

  12,500,000 

June 4, 2025

  -   3.18 
                
     17,400,000    4,900,000     

 

 

(1)

No share purchase warrants are exercisable until specific performance criteria have been met. Such criteria being 1) revenue sales projections per CTI’s 5 year proformas, or 2) listing on a major US exchange, or 3) change of control.